Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.
about
Matrix and backstage: cellular substrates for viral vaccinesGene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8⁺ T Cell EpitopesAn interaction quantitative trait loci tool implicates epistatic functional variants in an apoptosis pathway in smallpox vaccine eQTL data.Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine modelPreclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.Dual neonate vaccine platform against HIV-1 and M. tuberculosis.Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo.Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigensInterplay between modified vaccinia virus Ankara and dendritic cells: phenotypic and functional maturation of bystander dendritic cells.Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells.Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells.Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vectorEarly Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virusOncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimenAntibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDSTherapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines.Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection.Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.HIV/AIDS vaccines: a need for new concepts?Flow cytometry and the future of vaccine development.A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.Innate immune recognition of poxviral vaccine vectors.Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium.Protein kinase C overexpression does not enhance immune-stimulatory surface markers of vaccinia-infected dendritic cells and DC cell lines.Maternal Antibiotic Treatment Impacts Development of the Neonatal Intestinal Microbiome and Antiviral Immunity.Vaccinia virus encodes a novel inhibitor of apoptosis that associates with the apoptosome.Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein.Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDSCD70 encoded by modified vaccinia virus Ankara enhances CD8 T cell dependent protective immunity in MHC class II-deficient mice.
P2860
Q27025941-8EB917DF-81B8-4798-BEB3-25DEEB84D769Q28647428-8717FE70-5C2D-470C-8626-D86CF66FFC42Q31070382-657144E1-BA89-41A0-9D86-CCAD4D28F1B1Q33632203-AAF0AA7B-947D-461D-8644-9A766ACDC3EFQ33826983-1E9E149B-8F19-464E-8FB2-435564A822E8Q33908584-1732880A-2C0B-4954-BBA9-51DEE0EAABFDQ33913506-073538A6-B560-4238-8FBF-CF46872C03F6Q33916776-0A6DC573-FCE5-4875-ADF8-EF7BAFF0DA06Q34465228-E714160B-ED3C-4025-BC77-BCC5347BC0E4Q34982651-1891890B-37BA-4F53-B37A-EEA75D31BA94Q35013206-63C0DF4C-DA32-4414-9EF7-2444A9470A84Q35192675-03746FE1-B372-4A19-A022-01EC601CA392Q35567056-F1FAA65D-4173-41CC-8F26-D520FCB0998CQ35599411-B5990526-7181-4A10-8019-B61FE096DEB3Q35641132-DEB6B802-CC3F-4187-810C-0C67ECDF2930Q35943471-14C566CF-6AD3-469E-9A0D-D2A284A7634AQ35962511-B3AA222F-0B8F-4DB5-B9A5-AE7DAA424D52Q36099082-3C3506EC-3A2E-4F81-9B01-9ABCF42F4075Q36456190-B8C5C4BA-47A4-458B-AF6F-B3D6C7B36EC8Q36667821-1DCD08BA-3913-4A6B-BD7E-5C8E7C983365Q36849770-708D5D47-DA66-48DF-8625-E06A4996F8CDQ36961137-86636FC7-E205-4F44-B3CC-1FFCA54F4F6AQ37253001-121D3CB9-EF92-42AD-A2D3-AF6D2F54C89FQ37344236-5057F068-4B35-4CAB-A6D2-D59FEDA55CB8Q37503257-2848DA99-5B22-4F9A-9E62-B44F98FCB10AQ37656908-32E58FA0-686C-419F-A9B6-C2E8D8D6203BQ37944321-9295393B-2003-43DD-B52A-56031B500300Q38619090-B98BAC57-B944-4552-A796-7A099BF26925Q38970262-1FDD2026-35D9-4615-87FD-9B4B5F670FBEQ39207337-BD2A20FC-A91C-42B8-AA9E-1FDA988322A2Q39209632-E3EBC6E0-6CAA-4D45-8696-B7642379BACCQ39870861-12A184A1-BDE8-4C11-B72E-B181D7FC6DA5Q40042412-5F12CEC5-7695-49BD-816C-B69E917D0BCCQ40141904-DEFB2B12-73ED-446F-81B9-F5C31BFE4BC8Q42252735-031CA5D3-3A60-4B67-A9E4-4DB97EEDB559Q42575428-4938CA53-A576-47F0-9472-002EB59FED08Q47242631-ACA4AB26-9698-44D4-ADB3-C2890AF20F4A
P2860
Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@ast
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@en
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@nl
type
label
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@ast
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@en
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@nl
prefLabel
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@ast
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@en
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Dendritic cells are preferenti ...... ific T cell responses in vivo.
@en
P2093
Luzheng Liu
Mark B Feinberg
Rahul Chavan
P2860
P2888
P356
10.1186/1471-2172-9-15
P577
2008-04-15T00:00:00Z
P5875
P6179
1016828417